Feng Chen-chen, Ding Guan-xiong, Song Ning-hong, Li Xuan, Wu Zhong, Jiang Hao-wen, Ding Qiang
Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Tumour Biol. 2013 Dec;34(6):3471-6. doi: 10.1007/s13277-013-0924-7. Epub 2013 Jun 19.
To investigate the correlation between parathyroid hormone-related protein (PTHrP), erythropoietin (EPO), and vascular endothelial growth factor (VEGF) expression in clear cell renal cell carcinoma (ccRCC). Immunohistochemical studies on PTHrP, EPO and VEGF were performed in 249 patients with ccRCC. Serum calcium level and haematocrit were analyzed. The expression of the factors and clinicopathological parameters were studied statistically for possible correlations. The incidence for hypercalcaemia and polycythaemia were 15.3% and 2.0% respectively. Expression of PTHrP, EPO, and VEGF were respectively related to advanced stage (P < 0.0001 respectively). PTHrP was not related to tumour grade. Expressions of EPO and VEGF were correlated to tumour grade significantly. All factors were expressed higher in hypercalcaemic patients. PTHrP, EPO, and VEGF were positively correlated with each other in non-hypercalcaemic patients yet not in hypercalcaemic ones. PTHrP and EPO are related to VEGF expression and to the progression of ccRCC. This finding offers us new insight on the behaviour of ccRCC and offers possible targets in RCC treatment.
研究甲状旁腺激素相关蛋白(PTHrP)、促红细胞生成素(EPO)和血管内皮生长因子(VEGF)在透明细胞肾细胞癌(ccRCC)中的表达相关性。对249例ccRCC患者进行了PTHrP、EPO和VEGF的免疫组织化学研究。分析了血清钙水平和血细胞比容。对这些因子的表达与临床病理参数进行统计学研究以探讨可能的相关性。高钙血症和红细胞增多症的发生率分别为15.3%和2.0%。PTHrP、EPO和VEGF的表达分别与晚期相关(P均<0.0001)。PTHrP与肿瘤分级无关。EPO和VEGF的表达与肿瘤分级显著相关。所有因子在高钙血症患者中表达更高。在非高钙血症患者中,PTHrP、EPO和VEGF相互呈正相关,而在高钙血症患者中并非如此。PTHrP和EPO与VEGF表达及ccRCC的进展相关。这一发现为我们提供了关于ccRCC行为的新见解,并为RCC治疗提供了可能的靶点。